Barely Significant
← all excerpts

Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Curr Neuropharmacol · 2017 · PMC5652017 · PMID 28322166

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

showed a trendp=0.053so close (0.05 < p ≤ 0.1)
The decrease in Y-BOCS scores in the glycine compared to the placebo group showed a trend not reaching significance (p=0.053).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.